Skip to content
Open access

Brain age is associated with cognitive improvement following repetitive transcranial magnetic stimulation in late-life depression.

Jul 2026 · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · 0 citations · 67 references
Medicine

TL;DR

Brain age measures reflect cognitive, but not antidepressant, outcomes following rTMS in LLD, and Structural-MRI based centile scores may serve as biomarkers of cognitive function and predictors of rTMS-related cognitive improvement in individuals with LLD.

Abstract

Background

Late-life depression (LLD) is commonly accompanied by cognitive impairment and poor response to first-line antidepressants. Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for treatment-resistant LLD, yet neurobiological predictors of cognitive and clinical outcomes remain unclear. Brain aging, quantified via magnetic resonance imaging (MRI)-derived centile scores from normative brain charts, may capture individual variability in neurostructural aging relevant to rTMS treatment response.

Methods

We examined relationships between centile scores, cognition, and antidepressant outcomes in older adults with LLD (n=112) and healthy controls (HC; n=41) who participated in a noninferiority clinical trial of bilateral dorsolateral prefrontal cortex (DLPFC) rTMS versus theta burst stimulation. Structural MRI was obtained before and after treatment. Centile scores leveraging cortical and subcortical tissue volumes were generated using BrainChart.io. Cognitive outcomes were assessed using standardized neuropsychological measures, including verbal learning and executive function.

Results

Baseline centile scores did not differ between the LLD cohort and HCs and were unrelated to depression severity or antidepressant response. However, participants in a cognitively-diminished LLD subtype exhibited significantly lower centile scores driven by reduced white-matter volume. Across LLD participants, higher baseline centile scores predicted greater improvement in verbal learning following rTMS, but not global cognition or executive function, independent of antidepressant response. Centile scores remained stable post-treatment.

Conclusions

Brain age measures reflect cognitive, but not antidepressant, outcomes following rTMS in LLD. Structural-MRI based centile scores may serve as biomarkers of cognitive function and predictors of rTMS-related cognitive improvement in individuals with LLD.

Read PDF

Similar papers

Open access Sep 2026

Treatment response prediction in major neurocognitive disorder with depression using the scalp-to-cortex distance of TMS targets: implications for personalized dose estimation

Predictive models integrating with MRI-derived SCD and SCD-MOOD showed strong specificity for active rTMS compared to sham stimulation, and may enable the development of effective, personalized protocols to improve region-specific TMS treatment outcomes in clinical practice.

Hanna Lu, S. S. M. Chan, Suk L. Ma et al. · 0 citations
Open access Aug 2026

Advanced imaging–integrated rTMS therapy for frontal network recovery after traumatic brain injury

High-frequency left-DLPFC rTMS exposure was associated with improved executive recovery and measurable frontal-network modulation after traumatic brain injury and multimodal neurophysiological and imaging biomarkers may provide useful measures of target engagement for future prospective studies.

Nan Hu, Zhi-Ling Chen, Jian-Te Li et al. · 0 citations
Sep 2026

Neurophysiological Signatures of Negative Symptom Improvement After High-Definition Transcranial Direct Current Stimulation: A Transcranial Magnetic Stimulation-Electroencephalography Study.

Left DLPFC-targeted HD-tDCS improves negative symptoms in schizophrenia, potentially by restoring cortical inhibitory function, with exploratory evidence suggesting possible involvement of prefrontal-limbic network plasticity.

Meng Chen, De-Yang Li, Rong Zhu et al. · 0 citations
Open access Sep 2026

557. ECT-induced effects on brain structure, brain connectivity and cerebrospinal-fluid-based markers – a preliminary analysis

Abstract Background Electroconvulsive therapy (ECT) is among the most effective treatments for severe and treatment-resistant depression. Despite more than 90 years of clinical use, its underlying neurobiological mechanisms remain incompletely understood. One prominent hypothesis suggests that ECT induces neuroplastic...

P. Baldinger-Melich, S. Riessland, B. Spurny-Dworak et al. · 0 citations
Case report Open access Aug 2026

Cerebellar Perfusion Changes After Repetitive Deep Transcranial Magnetic Stimulation in Parkinson’s Disease: A Five-Patient Case Series and Literature Review

A five-patient exploratory case series evaluating clinical measures and cerebral perfusion before and three months after high-frequency dTMS targeting the supplementary motor area (SMA) suggests network-level modulation of SMA–cerebellar circuitry may reflect network-level modulation of SMA–cerebellar circuitry.

In-Uk Song, Yong-An Chung, Byungseok Kim et al. · 0 citations
Open access Sep 2026

262. Impact of adverse childhood experiences on brain stimulation outcomes for depression

While ACEs were prevalent among patients with MDD receiving brain stimulation treatment, the presence of more ACEs was not associated with poorer outcomes with acute high frequency rTMS treatment or with SCC-DBS treatment with long-term follow-up.

E. Ng, E. Wong, N. Lipsman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.